MIR129-1: A Potential Drug Target and Biomarker (G406917)
MIR129-1: A Potential Drug Target and Biomarker
MIR129-1, also known as MIRN129-1, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker in various diseases, including cancer. MIR129-1 is a small non-coding RNA molecule that plays a role in the regulation of gene expression and has been shown to be involved in the development and progression of various diseases.
One of the key features of MIR129-1 is its ability to interact with other molecules, including proteins and drugs. This interaction between MIR129-1 and other molecules has led to its potential as a drug target. By interacting with drugs, MIR129-1 can be inhibited, leading to a decrease in the activity of the drug and potentially a reduction in the development of cancer.
In addition to its potential as a drug target, MIR129-1 has also been identified as a potential biomarker for cancer. The expression of MIR129-1 has been shown to be elevated in various types of cancer, including breast, lung, and ovarian cancer. This increase in the expression of MIR129-1 may be a sign of the development of cancer and could potentially serve as a biomarker for cancer diagnosis and monitoring.
The potential drug target for MIR129-1 is its ability to interact with other molecules, including proteins and drugs. This interaction between MIR129-1 and other molecules has led to its potential as a drug target. By interacting with drugs, MIR129-1 can be inhibited, leading to a decrease in the activity of the drug and potentially a reduction in the development of cancer.
In addition to its potential as a drug target, MIR129-1 has also been identified as a potential biomarker for cancer. The expression of MIR129-1 has been shown to be elevated in various types of cancer, including breast, lung, and ovarian cancer. This increase in the expression of MIR129-1 may be a sign of the development of cancer and could potentially serve as a biomarker for cancer diagnosis and monitoring.
MIR129-1 has been shown to play a role in the regulation of gene expression in various types of cancer. For example, MIR129-1 has been shown to play a role in the regulation of the expression of the tumor suppressor gene, TP53. TP53 is a gene that plays a critical role in the regulation of cell growth and division, and is often mutated in cancer. MIR129-1 has been shown to interact with TP53 and can inhibit its activity, leading to an increase in the expression of genes that promote cancer growth.
In addition to its role in the regulation of gene expression, MIR129-1 has also been shown to play a role in the development and progression of cancer. For example, MIR129-1 has been shown to be involved in the regulation of the migration and invasion of cancer cells. Cancer cells are able to migrate and invade surrounding tissue, leading to the development of new tumors. MIR129-1 has been shown to play a role in the regulation of these processes and has been shown to promote the migration and invasion of cancer cells.
In conclusion, MIR129-1 is a small non-coding RNA molecule that has been identified as a potential drug target and biomarker in various diseases, including cancer. Its ability to interact with other molecules, including proteins and drugs, makes it a promising target for drug development. Additionally, its potential role in the regulation of gene expression and its involvement in the development and progression of cancer make it a promising biomarker for cancer diagnosis and
Protein Name: MicroRNA 129-1
The "MIR129-1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR129-1 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR129-2 | MIR1290 | MIR1291 | MIR1292 | MIR1293 | MIR1294 | MIR1295A | MIR1295B | MIR1296 | MIR1297 | MIR1298 | MIR1299 | MIR1301 | MIR1302-1 | MIR1302-10 | MIR1302-11 | MIR1302-2 | MIR1302-3 | MIR1302-4 | MIR1302-5 | MIR1302-6 | MIR1302-7 | MIR1302-8 | MIR1302-9 | MIR1303 | MIR1304 | MIR1305 | MIR1306 | MIR1307 | MIR130A | MIR130B | MIR132 | MIR1321 | MIR1322 | MIR1323 | MIR1324 | MIR133A1 | MIR133A1HG | MIR133A2 | MIR133B | MIR134 | MIR1343 | MIR135A1 | MIR135A2 | MIR135B | MIR136 | MIR137 | MIR137HG | MIR138-1 | MIR138-2 | MIR139 | MIR140 | MIR141 | MIR142 | MIR143 | MIR144 | MIR145 | MIR1468 | MIR1469 | MIR146A | MIR146B | MIR1470 | MIR1471 | MIR147A | MIR147B | MIR148A | MIR148B | MIR149 | MIR150 | MIR151A | MIR151B | MIR152 | MIR153-1 | MIR153-2 | MIR1537 | MIR1538 | MIR1539 | MIR154 | MIR155 | MIR155HG | MIR1587 | MIR15A | MIR15B | MIR16-1 | MIR16-2 | MIR17 | MIR17HG | MIR181A1 | MIR181A1HG | MIR181A2 | MIR181A2HG | MIR181B1 | MIR181B2 | MIR181C | MIR181D | MIR182 | MIR1825 | MIR1827 | MIR183 | MIR184
